Does DOSTARLIMAB Cause Condition aggravated? 27 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Condition aggravated have been filed in association with DOSTARLIMAB (Jemperli). This represents 3.0% of all adverse event reports for DOSTARLIMAB.
27
Reports of Condition aggravated with DOSTARLIMAB
3.0%
of all DOSTARLIMAB reports
7
Deaths
14
Hospitalizations
How Dangerous Is Condition aggravated From DOSTARLIMAB?
Of the 27 reports, 7 (25.9%) resulted in death, 14 (51.9%) required hospitalization, and 2 (7.4%) were considered life-threatening.
Is Condition aggravated Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DOSTARLIMAB. However, 27 reports have been filed with the FAERS database.
What Other Side Effects Does DOSTARLIMAB Cause?
Malignant neoplasm progression (111)
Thrombocytopenia (42)
Fatigue (38)
Anaemia (36)
Death (31)
Arthralgia (30)
Diarrhoea (29)
Rash (29)
Dyspnoea (26)
Nausea (26)
What Other Drugs Cause Condition aggravated?
TOFACITINIB (16,925)
INFLIXIMAB (16,616)
DUPILUMAB (16,459)
ETANERCEPT (15,897)
METHOTREXATE (14,938)
ADALIMUMAB (13,527)
PREDNISONE (10,751)
INFLIXIMAB-DYYB (10,275)
HYDROXYCHLOROQUINE (8,848)
RITUXIMAB (8,627)
Which DOSTARLIMAB Alternatives Have Lower Condition aggravated Risk?
DOSTARLIMAB vs DOSTARLIMAB-GXLY
DOSTARLIMAB vs DOTATATE GALLIUM GA-68
DOSTARLIMAB vs DOTHIEPIN
DOSTARLIMAB vs DOXAZOSIN
DOSTARLIMAB vs DOXAZOSIN\DOXAZOSIN